ATF3 elevation, in turn, stimulates increased expression of ABCB1 efflux pumps resulting in enhanced tamoxifen efflux conferring the breast cancer cells' resistance to this drug.[62]. This evidence concerns the gene ATF3 and breast carcinoma.